ACTIVE

APOTHEEK WINTERSLAG

Financial year 2025 · Closed on 31/12/2025

Net result49,5 k €-73,2 %over 1 year
Gross margin236,2 k €-41,1 %over 1 year
Equity99,1 k €0,0 %over 1 year
Workforce1,9 ETP

Identity

Source · BCE/KBO

APOTHEEK WINTERSLAG is a Public limited company incorporated in 1999. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Genk. It employs on average 1,9 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0466.616.817
Incorporation
27/07/1999
Legal form
Public limited company
Registered office
Acacialaan 30
3600 Genk · FlandreSee on map
Contributed capital
65 000,00 €
Latest accounts
31/12/2025
Average workforce
1,9 ETP
Joint committees (2)
  • 313
  • 31300
Signals
ProfitableLow riskPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 20 filings

Trend over 20 financial years

20252024202320222021
Income statement
Gross margin236,2 k €401 k €313 k €470,9 k €774,3 k €
EBITDA89,2 k €236,7 k €207,9 k €307,9 k €583,7 k €
Operating result71,8 k €219,2 k €193,2 k €297,8 k €519 k €
Net result49,5 k €184,4 k €187,5 k €270,6 k €574,3 k €
Balance sheet
Equity99,1 k €99,1 k €99,1 k €98,6 k €98 k €
Total assets604,2 k €713,2 k €698,6 k €770,5 k €2,3 M €
Cash204,1 k €205,1 k €163,8 k €169,9 k €1,1 M €
Debts503,3 k €609,8 k €592,5 k €669,1 k €2,2 M €
Other
Workforce1,9 ETP––3,0 ETP3,6 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 11 ended

Active mandates

SLEYPEN FARMA

Director · since 01 janvier 2023 · 0536.486.610

Represented by Tim SLEYPEN

Active

Ended mandates

SLEYPEN FARMA

Director · since 01 janvier 2023 · 0536.486.610

Represented by Tim SLEYPEN

Ended
ACACIA MANAGEMENT

Director · since 01 octobre 2018 · until 30 mai 2024 · 0466.160.719

Represented by Alfons Boeckmans

Ended
ACACIA MANAGEMENT

Managing director · since 01 octobre 2018 · until 30 mai 2024 · 0466.160.719

Ended
JOOST BOECKMANS

Director · since 01 octobre 2018 · until 30 mai 2024

Ended

Full financial information

Source · NBB
202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date22/06/202625/07/202505/07/202431/08/202314/07/202225/06/2021
General meeting28/05/202629/05/202530/05/202425/05/202326/05/202227/05/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 20 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202528/05/202622/06/2026DutchPDF
Abridged model31/12/202429/05/202525/07/2025DutchPDF
Abridged model31/12/202330/05/202405/07/2024DutchPDF
Abridged model31/12/202225/05/202331/08/2023DutchPDF
Abridged model31/12/202126/05/202214/07/2022DutchPDF
Abridged model31/12/202027/05/202125/06/2021DutchPDF
Abridged model31/12/201928/05/202030/06/2020DutchPDF
Abridged model31/12/201831/05/201925/07/2019DutchPDF
Abridged model31/12/201731/05/201826/06/2018DutchPDF
Abridged model31/12/201626/05/201720/06/2017DutchPDF
Abridged model31/12/201526/05/201614/06/2016DutchPDF
Abridged model31/12/201428/05/201506/07/2015DutchPDF
Abridged model31/12/201330/05/201406/06/2014DutchPDF
Abridged model31/12/201230/05/201325/06/2013DutchPDF
Abridged model31/12/201131/05/201211/06/2012DutchPDF
Abridged model31/12/201026/05/201107/07/2011DutchPDF
Abridged model31/12/200927/05/201008/06/2010DutchPDF
Abridged model31/12/200828/05/200902/06/2009DutchPDF
Abridged model31/12/200729/05/200813/06/2008DutchPDF
Abridged model31/12/200621/06/200728/06/2007DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 11 ended

Active mandates

SLEYPEN FARMA

Director · since 01 janvier 2023 · 0536.486.610

Represented by Tim SLEYPEN

Active

Ended mandates

SLEYPEN FARMA

Director · since 01 janvier 2023 · 0536.486.610

Represented by Tim SLEYPEN

Ended
ACACIA MANAGEMENT

Director · since 01 octobre 2018 · until 30 mai 2024 · 0466.160.719

Represented by Alfons Boeckmans

Ended
ACACIA MANAGEMENT

Managing director · since 01 octobre 2018 · until 30 mai 2024 · 0466.160.719

Ended
JOOST BOECKMANS

Director · since 01 octobre 2018 · until 30 mai 2024

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates06/03/2023
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - DOEL - KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates07/05/2019
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates06/11/2018
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates31/08/2016
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates23/03/2012
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates22/12/2004
    ONTSLAGEN - BENOEMINGEN
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 202549,5 k €↓
  2. 2024
    Annual accounts 2024184,4 k €↓
  3. 2023
    Annual accounts 2023187,5 k €↓
  4. 2022
    Annual accounts 2022270,6 k €↓
  5. 2022
    Name changeApotheek Winterslag
  6. 2021
    Annual accounts 2021574,3 k €↑
  7. 2021
    Name changeFARMACACIA
  8. 2020
    Annual accounts 2020461 k €↑
  9. 2019
    Annual accounts 2019436,9 k €↓
  10. 2018
    Annual accounts 2018450,7 k €↑
  11. 2017
    Annual accounts 2017426,8 k €↑
  12. 2016
    Annual accounts 2016388,7 k €↑
  13. 2015
    Annual accounts 2015370,6 k €↑
  14. 2014
    Annual accounts 2014322,2 k €↑
  15. 2013
    Annual accounts 2013236,5 k €↑
  16. 2012
    Annual accounts 2012159,8 k €↓
  17. 2011
    Annual accounts 2011283,3 k €↑
  18. 2010
    Annual accounts 2010151,1 k €↑
  19. 2009
    Annual accounts 2009148,9 k €↓
  20. 2008
    Annual accounts 2008169,2 k €↓
  21. 2007
    Annual accounts 2007172,7 k €↑
  22. 2006
    Annual accounts 2006170,2 k €
  23. 27/07/1999
    IncorporationPublic limited company